Cryo-EM focused biotech from longtime NIH veteran secures $40M backing from Bayer in Series A

“It’s always nice to get money in the bank.”

That’s what Gandeeva Therapeutics’ founder and CEO Sriram Subramaniam said, after revealing that his company landed $40 million in Series A funding. Gandeeva will use the money for its artificial intelligence-enabled platform to identify small molecules and biologics at a faster...

Click to view original post